About 600 reports

April 2017: Fresenius acquired Merck' s biosimilar portfolio, which includes products for both oncology and autoimmune diseases, for €##M ($##M).

  • Targeted Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

• The global antibody drugs market for autoimmune diseases reached $##. ## billion in 2016.

  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • World
  • Market Shares
  • IMPACT OF DRIVERS AND CHALLENGES
  • Phase I

CANCER GLOBAL INCIDENCE OF CANCERS 2015 AND 2020 AUTOIMMUNE DISEASES According to the National Health Service (NHS), about one in ##, ## people is affected with CD.

  • Targeted Therapy
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

ANTI-CANCER IS HIGH AND AUTOIMMUNE IS USUALLY CONSTRAINED MORE SO BY THE PAIRS BECAUSE AUTOIMMUNE DISEASE IS CONSIDERED AS CANCER.

  • Targeted Therapy
  • World
  • Market Size
  • AbbVie Inc.
  • Sanofi S.A.
  • 3.1 CATALYST

OPPORTUNITY ## EXTENSION INTO OTHER AUTOIMMUNE DISEASES SUCH AS CD AND PSORIATIC ARTHRITIS.

  • Targeted Therapy
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Pfizer Inc.
  • Remicade group

ANTI-CANCER IS HIGH AND AUTOIMMUNE IS USUALLY CONSTRAINED MORE SO BY THE PAIRS BECAUSE AUTOIMMUNE DISEASE IS CONSIDERED AS CANCER.

  • Targeted Therapy
  • World
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.

JAKINIBS: A NEW CLASS OF KINASE INHIBITORS IN CANCER AND AUTOIMMUNE DISEASE.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

Autoimmune diseases ##. ##. ##.

  • Pharmaceutical
  • Targeted Therapy
  • APAC
  • World
  • Market Size
  • IMPACT OF DRIVERS AND CHALLENGES
  • Phase I

CANCER GLOBAL INCIDENCE OF CANCERS 2015 AND 2020 AUTOIMMUNE DISEASES According to the National Health Service (NHS), about one in ##, ## people is affected with CD.

  • Targeted Therapy
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • AVERAGE ANNUAL TREATMENT COST OF ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB 2014 ($ MILLIONS)
  • THE REGULATORY FILING FOR THE EXTENDED APPROVALS OF THE DRUGS IS ALSO EXPECTED TO INCREASE THEIR RECOGNITION AND ACCEPTANCE.

About Monoclonal Antibodies Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific,...

  • Targeted Therapy
  • World
  • Market Size
  • AbbVie Inc.
  • Amgen Inc.

You can request one free hour of our analyst’s time when you purchase this market report.

  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • World
  • Market Size
  • 7.9.5 Forecast
  • OPPORTUNITY 3 POSTPONED LAUNCH OF ADALIMUMAB BIOSIMILARS IN THE US UNTIL 2023.

ARCHIVES OF DISEASE IN CHILDHOOD; ##: ##-##.

  • Targeted Therapy
  • United States
  • AbbVie Inc.
  • Celgene Corporation
  • Remicade group
  • TIMELINE OF NOTABLE EVENTS IN THERAPEUTIC MAB DEVELOPMENT
  • 3.1.3 By Mechanism of Action

This subset of mAbs has shown strong promise in oncology, and also has potential for the treatment of autoimmune diseases (Cretney et al., 2006).

  • Targeted Therapy
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson
  • Tyrosine Protein Kinase JAK1

The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.

  • Targeted Therapy
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

Abstract Psoriasis (PsO) is a chronic autoimmune disease that results from the overproduction of skin cells that causes redness and inflammation.

  • Anti Rheumatic
  • Autoimmune Disease
  • Targeted Therapy
  • United States
  • World

Both diseases affect the GI system with similar symptoms while the course of the diseases and treatments may be different.

  • Anti Rheumatic
  • Targeted Therapy
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ankylosing Spondylitis Market by Segment, U. S., ##

  • Anti Rheumatic
  • Targeted Therapy
  • Therapy
  • United States
  • World

Therefore, the market is segmented by diseases.

  • Anti Rheumatic
  • Autoimmune Disease
  • Targeted Therapy
  • United States
  • World
  • 7.2.3 CELLTRION INC. - MAJOR BIOSIMILARS APPROVED FOR MARKETING
  • 7.2.2 CELLTRION INC. - ANNUAL REVENUE (2013 - 2015)

In the next few years several major biologicals in oncology and the treatment of autoimmune diseases, accounting for more than Euros ## billion in spending, will lose their patent protection, opening the door to biosimilars.

  • Targeted Therapy
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

Press release ## Seattle Genetics initiates clinical trial of Adcetris (brentuximab vedotin) in systemic lupus erythematosus, a chronic autoimmune disease BOTHELL, Wash.

  • Targeted Therapy
  • North America
  • United States
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • J&J'S UC PORTFOLIO ASSESSMENT, 2015

UC IS KNOWN TO BE ASSOCIATED WITH AUTOIMMUNE DISEASES, INCLUDING AUTOIMMUNE HEPATITIS AND AUTOIMMUNE PANCREATITIS.

  • Targeted Therapy
  • Market Size
  • EA Pharma Co., Ltd.
  • Pfizer Inc.
  • Remicade group
  • 4.3.4 AGGREGATE CLINICAL PROGRAM SIZE

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha ## beta ## integrin.

  • Targeted Therapy
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Cancer Treatment Antibody Major Producer and Their

This study focuses on China’s Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Targeted Therapy
  • China
  • Demand
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

Manufactures biological products and generic biotechnological drugs for indications such as autoimmune diseases, hematology, reproductive health, oncology, and viral infections.

  • Targeted Therapy
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group

The collaboration will focus on developing drug candidates to treat autoimmune diseases, including rheumatoid arthritis and psoriasis.

  • Targeted Therapy
  • World
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.

Annals of Rheumatology Diseases; ##-##.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.